期刊文献+

宫颈癌中p27^(Kip1)基因的表达与体外药物敏感性的关系 被引量:3

Relationship between the expression of p27^(Kip1) and chemosensitivity of cervical carcinoma in vitro
下载PDF
导出
摘要 背景与目的:p27K ip1基因是调控细胞周期并抑制细胞分裂的重要基因。它与诱导肿瘤细胞的凋亡和化疗药物的耐药也有关系。本文旨在探讨宫颈癌组织中p27K ip1基因的表达与体外药敏的关系。方法:采用MTT法检测了部分化疗药物在46例宫颈癌组织中的抑制率,并采用免疫组织化学方法检测了癌组织中p27K ip1基因的表达。结果:宫颈癌组织中p27K ip1表达的阳性率为15.2%(7/46)。顺铂(DDP)、表柔比星(E-ADM)、替尼泊苷(VM26)、紫杉醇(Taxol)、吉西他滨(Gem zar)、氟尿嘧啶(5-FU)和BLM的平均抑制率分别为47.6%、38.0%、42.7%、27.4%、23.0%、26.3%和24.8%。DDP、VM26和Taxol在p27K ip1表达阴性的宫颈癌标本中的抑制率显著低于阳性标本(P<0.05),而在其他药物中差异无显著性。结论:p27K ip1的表达可作为判断肿瘤对化疗药物的敏感性的指标,指导临床用药。 Background and Purpose: p27^Kip1 is an important gene that inhibits cellular division and regulates cell cycle, it promotes cell apoptosis, and is also related to chemotherapeutic drug tolerance. This paper is to study the relationship between the expression of p27^Kip1 and chemosensitivity of cervical carcinoma in vitro. Methods: We used MTT assay to detect the inhibitory rate of some chemotherapeutic drugs in 46 samples of cervical carcinoma in vitro. The expression level of p27^Kip1 was detected by immunohistochemistry method. Results: The positive rate of p27^Kip1 of cervical carcinoma was 15. 2% (7/46). The average inhibitory rates of DDP, E-ADM, VM26, Taxol, Gemzar, 5-Fu and BLM were 47.6%, 38.0%, 42.7%, 27.4%, 23.0%, 26.3% and 24.8%, respectively. The inhibitory rates of DDP, VM26, Taxol in the cervical carcinoma with p27^Kip1 negative were significantly lower than those with p27^Kip1 positive samples (P 〈0.05). However there were no significant differences in the other therapeutic drugs. Conclusions: The expression of p27^Kip1 can be used to detect the chemosensitivity in cervical carcinoma and direct drug administration.
出处 《中国癌症杂志》 CAS CSCD 2006年第1期39-41,共3页 China Oncology
关键词 宫颈癌 P27^KIP1 MTT法 体外药敏 耐药 cervical carcinoma p27^Kip1 MTT assay chemosensitivity in vitro drug resistance
  • 相关文献

参考文献10

  • 1Goff BA, Sallin J, Gareia R, et al. Evaluation of p27 in preinvasive and invasive malignancies of the cervix[J].Gynecol Oncol,2003,88(1):40-44.
  • 2Huang LW,Chao SL,Hwang JL,et al.Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms[J].Gynecol Oncol,2002,85(3);524-528.
  • 3Shiozawa T, Shiohara S, Kanai M, et al. Expuession of the cell eycle regulator p27^kip1 in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix[J].Cancer,2001,92(12):3005-3011.
  • 4Kim YT,Choi EK,Cho NH,et al.Expression of cyclin E and p27^KIP1 in cervical carcinoma[J].Cancer Letters,2000,153(1-2):41-50.
  • 5Mosmann T.Rapid colorimetrie assay for cellular growth and survival:application to proliferation and cytotoxicity assays[J].J Immnol Methods,1983,65(1-2):55-63.
  • 6Kuo MY,Hsu HY,Kok SH,et al.Prognostic role of p27(Kip1)expression in oral squamous cell carcinoma in Taiwan[J].Oral Oncol,2002,38(2):172-178.
  • 7Tsukamoto S,Sugio K.Sakada T,et al.Reduced expression of cell-cycle regulator p27(Kip1)correlates with a shortened survival in non-small-cell lung cancer[J].Lung Cancer,2001,34(1):83-90.
  • 8Oshita F,Kameda Y,Nishio K,et al.Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small-cell lung cancer[J].Oncol Rep,2000,7(3);491-495.
  • 9Goff BA, Paley PJ, Greer BE, et al. Evaluation of chemoresistance markers in vomen with epithelial ovarian carcinoma [ J ].Gynecol Oncol,2001,81 ( 1 ) : 18-24.
  • 10Yang Q, Sakurai T, Yoshimura G, el al, Overexpression of p27 protein in human breast cancer correlates with in vitro resislance to doxorubicin and mitomycin C [ J ]. Anticancer Res, 2000,20(6B) :4319-4122.

同被引文献34

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部